Oxeia Biopharmaceuticals develops novel therapeutics for patients with concussions.

Because rest is not enough

What’s New…

Oxeia Biopharma In the News

NB Science Cafe: Dr. Michael Wyand

Drug Discovery World Podcast: The unmet critical need for concussion drug therapies

Drug Discovery World: Neuroscience: Advances in research and opportunities ahead

Drug Discovery World: Developments in Concussion Therapies

ACRM: Results of Research at the University of Kansas Medical Center

These stories and more…

Oxeia Biopharmaceuticals is a team of passionate scientists, biotech leaders, and athletes dedicated to bringing a safe and effective concussion therapy to market.

REST IS NOT ENOUGH.

More About What We Do